Product Code: RP-ID-10013428 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013428
Market Overview:
Animal Model Market Size study, by Type (Rats, Mice, Others), by Application (Labs, Academic and Research Institute) and Regional Forecasts 2018-2025
Animal Model Market to reach USD 965.7 million by 2025.
Animal Model Market valued approximately USD 574.81 million in 2017 is anticipated to grow with a healthy growth rate of more than 6.70% over the forecast period 2018-2025. Increasing applications of animal species in a way to develop many novel therapy is likely to raise the growth of animal model market as well as rapid advancements in novel technologies and growing different types of genetic disorders across the globe are the major driving which fueling the demand of animal model market across the globe. One of the major restraining factor of global animal model market is concentrated that animal model have been deemed less effective for human disease research. Significantly incident rate of diseases along with adverse effects of drugs build-up various opportunities in global animal model market. The animal in which the pathological and the biological studies are done and tested such animal is referred as an animal model. The animal models are used as it has a functional resemblance to the human body. There are various guidelines that have to be followed while taking an animal model for to the experiment. The advantages of animal model research is that it puts no risk on the human lives. Experiments can takes place to determine, if a product or idea will work as intended. If it does, then it can be tested on humans with a lower risk of a negative outcome
The regional analysis of Animal Model Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share in animal model market. In the animal model research, significant investments that are made in the favor with relevant policies which is reformed by North American Government to encourage the funds. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
• Rats
• Mice
• Others
By Application:
• Labs
• Academic and Research Institute
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
The industry is seeming to be fairly competitive. Some of the leading market players include Charles River laboratory, Advinus Therapeutics, Beijing Vital Star Biotechnology Co. Ltd.
Crown Biosciences, Envigo, Genoway, Horizon Discovery Group, Jackson Laboratory,, Pharmalegacy Biotechnology, Pharmaron, Psychogenics Inc., Shanghai Medicilon and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Animal Model Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Advinus Therapeutics
Beijing Vital Star Biotechnology Co. Ltd.
Crown Biosciences
Envigo
Genoway
Horizon Discovery Group
Jackson Laboratory
Pharmalegacy Biotechnology
Pharmaron
Psychogenics Inc.
Shanghai Medicilon
Related Reports
Proof of Quality & Reliability
